EIF4EBP1 and breast carcinoma: According to Shin et al. [31], GSK-3β directly phosphorylates 4EBP1 at Thr37/46 and inactivates 4EBP1 activity in breast cancer and normal cell lines, thereby increasing eIF4E-dependent protein synthesis and regulating cell proliferation.